Louwai Muhammed is the Chief Executive Officer and Co-Founder of CoSyne Therapeutics. They have a background in neurology, having worked as a Neurology Registrar at NHS. They also have experience as a Core Medical Doctor and Academic Foundation Doctor. Louwai Muhammed holds a Master's Degree from Harvard University and a BM BCh in Medicine from the University of Oxford. Additionally, they have a MA in Medicine (Neuroscience) from the University of Cambridge and a degree in Neuroscience and Technology from Massachusetts Institute of Technology. Their educational journey began at The Coopers' Company and Coborn School where they completed their A2 Level.